Kyle Zingaro
Head of Gene Therapy Process Sciences at UCB | Braine-l’Alleud, Walloon Region, Belgium
Kyle Zingaro’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Kyle Zingaro currently serves as the Head of Gene Therapy Process Sciences at UCB, where he directs innovation-focused biologics development and drives strategic improvements across CMC drug development programs. Drawing on his education from the University of Delaware, he operates from the company’s Braine-l’Alleud location while advancing manufacturing strategies for severe central nervous system and immunological therapies. His recognized expertise centers on scaling complex gene therapy platforms to support clinical and commercial production within the biotechnology sector.
BEST APPROACH TO REACH Kyle Zingaro
Reach out via personal email, utilizing your high-confidence directory match for this channel, and initiate contact by aligning your capabilities with his current mandate to optimize gene therapy manufacturing processes at UCB.
Head of Gene Therapy Process Sciences at UCB in October 2020 - Present
Head of Process Sciences, Viral Vector Services at Thermo Fisher Scientific in May 2019 - September 2020
Director, Process Sciences at Brammer Bio in December 2018 - May 2019
Associate Director, Upstream MSAT at Brammer Bio in June 2018 - December 2018
Development Scientist II, Early Stage Process Development at Alexion Pharmaceuticals, Inc. in January 2016 - June 2018
Development Scientist, Upstream Development at Alexion Pharmaceuticals, Inc. in October 2013 - January 2016
PhD Candidate at University of Delaware in August 2009 - October 2013
Scientist at PPD in June 2007 - June 2009
University of Delaware, Doctor of Philosophy (Ph.D.), July 2026
Virginia Tech, BS, July 2026
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.
Discover more about UCB
Head of Business Excellence, Patient Supply at UCB
Sr Director, Head of Business Excellence at UCB
(September 2024 – Present)
Senior Project Leader
Senior Project Leader at UCB
(June 2025 – Present)
Head of Clinical Supply Chain
Head of Clinical Supply Chain at UCB
(September 2024 – Present)
Global TA&L Launch Excellence Lead
Global TA&L Launch Excellence Lead at UCB
(June 2022 – Present)
Head of Safety Histology | PhD
Senior Scientist at UCB
(October 2020 – Present)
Gene Therapy Process Engineering Lead
Gene Therapy Process Engineering Lead at UCB
(September 2024 – Present)
What is Kyle Zingaro email address?
Email Kyle Zingaro at [email protected] and [email protected]. This email is the most updated Kyle Zingaro's email found in 2026.
How to contact Kyle Zingaro?
To contact Kyle Zingaro send an email to [email protected] or [email protected]. (updated on November 11, 2025)
What company does Kyle Zingaro work for?
Kyle Zingaro works for UCB.
What is Kyle Zingaro's role at UCB?
Kyle Zingaro is Head of Gene Therapy Process Sciences
What industry does Kyle Zingaro work in?
Kyle Zingaro works in the Biotechnology industry.
